159 related articles for article (PubMed ID: 2035841)
1. Intramolecularly quenched fluorogenic tetrapeptide substrates for tissue and plasma kallikreins.
Chagas JR; Juliano L; Prado ES
Anal Biochem; 1991 Feb; 192(2):419-25. PubMed ID: 2035841
[TBL] [Abstract][Full Text] [Related]
2. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
[TBL] [Abstract][Full Text] [Related]
3. Substrate specificities of tissue kallikrein and T-kininogenase: their possible role in kininogen processing.
Chagas JR; Hirata IY; Juliano MA; Xiong W; Wang C; Chao J; Juliano L; Prado ES
Biochemistry; 1992 Jun; 31(21):4969-74. PubMed ID: 1599922
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and hydrolysis by cysteine and serine proteases of short internally quenched fluorogenic peptides.
Melo RL; Alves LC; Del Nery E; Juliano L; Juliano MA
Anal Biochem; 2001 Jun; 293(1):71-7. PubMed ID: 11373081
[TBL] [Abstract][Full Text] [Related]
5. Characterization of kininogenase activity of an acidic proteinase isolated from human kidney.
Gomes RA; Juliano L; Chagas JR; Hial V
Can J Physiol Pharmacol; 1997 Jun; 75(6):757-61. PubMed ID: 9276160
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments.
Del Nery E; Chagas JR; Juliano MA; Prado ES; Juliano L
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):233-8. PubMed ID: 7492318
[TBL] [Abstract][Full Text] [Related]
7. Human tissue kallikrein S1 subsite recognition of non-natural basic amino acids.
Melo RL; Barbosa Pozzo RC; Pimenta DC; Perissutti E; Caliendo G; Santagada V; Juliano L; Juliano MA
Biochemistry; 2001 May; 40(17):5226-32. PubMed ID: 11318645
[TBL] [Abstract][Full Text] [Related]
8. Specificity of human tissue kallikrein towards substrates containing Phe-Phe pair of amino acids.
Pimenta DC; Chao J; Chao L; Juliano MA; Juliano L
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):473-9. PubMed ID: 10191281
[TBL] [Abstract][Full Text] [Related]
9. Tetrapeptide substrates for the discrimination among kallikreins and other trypsin-like serine proteinases.
Prado ES; Araújo-Viel MS; Juliano MA; Juliano L; Stella RC; Sampaio CA
Biol Chem Hoppe Seyler; 1986 Mar; 367(3):199-205. PubMed ID: 3518738
[TBL] [Abstract][Full Text] [Related]
10. Tissue kallikreins and related enzymes: characterization by model oligopeptides.
Prado ES; Juliano L; Araújo-Viel MS; Juliano MA
Adv Exp Med Biol; 1986; 198 Pt A():241-6. PubMed ID: 3643710
[TBL] [Abstract][Full Text] [Related]
11. Intramolecularly quenched fluorogenic peptide substrates for human renin.
Oliveira MC; Hirata IY; Chagas JR; Boschcov P; Gomes RA; Figueiredo AF; Juliano L
Anal Biochem; 1992 May; 203(1):39-46. PubMed ID: 1524216
[TBL] [Abstract][Full Text] [Related]
12. Chromogenic and fluorogenic glycosylated and acetylglycosylated peptides as substrates for serine, thiol and aspartyl proteases.
Juliano MA; Filira F; Gobbo M; Rocchi R; Del Nery E; Juliano L
J Pept Res; 1999 Feb; 53(2):109-19. PubMed ID: 10195448
[TBL] [Abstract][Full Text] [Related]
13. Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors.
Pimenta DC; Fogaça SE; Melo RL; Juliano L; Juliano MA
Biochem J; 2003 May; 371(Pt 3):1021-5. PubMed ID: 12578561
[TBL] [Abstract][Full Text] [Related]
14. [New dipeptide fluorogenic substrates of human tissue kallikrein].
Pozdnev VF; Rabinovich SE; Paskhina TS
Bioorg Khim; 1991 Oct; 17(10):1352-6. PubMed ID: 1804119
[TBL] [Abstract][Full Text] [Related]
15. New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase.
Morita T; Kato H; Iwanaga S; Takada K; Kimura T
J Biochem; 1977 Nov; 82(5):1495-8. PubMed ID: 591514
[TBL] [Abstract][Full Text] [Related]
16. Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins.
Fogaça SE; Melo RL; Pimenta DC; Hosoi K; Juliano L; Juliano MA
Biochem J; 2004 Jun; 380(Pt 3):775-81. PubMed ID: 15040788
[TBL] [Abstract][Full Text] [Related]
17. Internally quenched fluorogenic substrates for angiotensin I-converting enzyme.
Araujo MC; Melo RI; Del Nery E; Alves MF; Juliano MA; Casarini DE; Juliano L; Carmona AK
J Hypertens; 1999 May; 17(5):665-72. PubMed ID: 10403610
[TBL] [Abstract][Full Text] [Related]
18. Comparison of human and porcine tissue kallikrein substrate specificities.
Del Nery E; Chagas JR; Juliano MA; Juliano L; Prado ES
Immunopharmacology; 1999 Dec; 45(1-3):151-7. PubMed ID: 10615005
[TBL] [Abstract][Full Text] [Related]
19. Structural features that make oligopeptides susceptible substrates for hydrolysis by recombinant thimet oligopeptidase.
Camargo AC; Gomes MD; Reichl AP; Ferro ES; Jacchieri S; Hirata IY; Juliano L
Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):517-22. PubMed ID: 9182712
[TBL] [Abstract][Full Text] [Related]
20. A highly selective assay for neutral endopeptidase based on the cleavage of a fluorogenic substrate related to Leu-enkephalin.
Carvalho KM; Boileau G; Camargo AC; Juliano L
Anal Biochem; 1996 Jun; 237(2):167-73. PubMed ID: 8660561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
